Stocks TelegraphStocks Telegraph
Stock Ideas

ST Premium

Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.

Try Now for Just $1!

NVO Financial Statements and Analysis

NYSE : NVO

Novo Nordisk A/S

$50.03
-3.91-7.25%
At Close 4:00 PM
58.48
BESG ScoreESG Rating

FINANCIAL STATEMENTS

An instrumental part of fundamental analysis is measuring key indicators of an asset, which are the factors that can influence its value and price. However, sometimes investors show more interest in financial statements with other factors to determine whether investing in that company is the right decision. Financial statements of a company include:

  • Balance Sheet
  • Income Statement
  • Cash Flow Statement

Income Statement

A company's income statement helps investors and business owners determine whether the company is profitable or losing money. Profitability is a key factor investors consider before investing in a stock. Income statements provide them with information about a company's profitability over time. The statement also enables them to observe trends in company spending and earnings since it breaks down individual costs and revenues. Income statements also provide details on where a company's money is going when it isn't profitable or its profits fluctuate.

DateMar 31, 2025Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023
reported currencyDKKDKKDKKDKKDKK
calendar year20252024202420242023
periodQ1Q3Q2Q1Q4
revenue78.087B71.311B68.06B65.349B65.863B
cost of revenue12.89B11.308B10.274B9.916B10.014B
gross profit65.197B60.003B57.786B55.433B55.849B
gross profit ratio0.8350.8410.8490.8480.848
research and development expenses10.308B9.488B16.166B8.606B10.46B
general and administrative expenses1.22B1.382B1.157B1.157B1.456B
selling and marketing expenses14.892B15.21B14.934B13.256B17.17B
selling general and administrative expenses16.112B16.592B16.091B14.413B18.626B
other expenses-14.00M0-405.00M00
operating expenses26.406B26.08B32.257B23.019B29.083B
cost and expenses39.296B37.388B42.531B32.935B39.097B
interest income3.425B1.383B960.00M2.146B-2.82B
interest expense5.183B821.00M1.562B2.074B-2.101B
depreciation and amortization3.83B2.15B8.845B2.914B2.992B
ebitda46.046B37.355B35.739B35.328B28.511B
ebitda ratio0.590.5240.5050.5410.433
operating income38.791B33.923B25.529B32.414B26.766B
operating income ratio0.4970.4760.3750.4960.406
total other income expenses net-1.758B461.00M-602.00M-496.00M854.00M
income before tax37.033B34.384B25.332B31.918B27.62B
income before tax ratio0.4740.4820.3720.4880.419
income tax expense7.999B7.083B5.282B6.511B5.657B
net income29.034B27.301B20.05B25.407B21.963B
net income ratio0.3720.3830.2950.3890.333
eps6.546.134.505.704.92
eps diluted6.536.124.495.684.91
weighted average shs out4.44B4.454B4.458B4.46B4.465B
weighted average shs out dil4.446B4.461B4.465B4.471B4.477B
Graph

Balance Sheet

Balance sheet summarizes a company's financials and can be used as a basis by investors to determine the value of a company. It shows the value of the stock, as well as the assets and liabilities of the company. A company's balance sheet displays how its assets are put to use and how those assets are financed, based on the liabilities section. Both investors and analysts analyze a company's balance sheet to determine how it allocates its resources.

DateMar 31, 2025Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023
reported currencyDKKDKKDKKDKKDKK
calendar year20252024202420242023
periodQ1Q3Q2Q1Q4
cash and cash equivalents38.938B57.018B52.821B6.324B14.392B
short term investments2.612B17.863B9.833B2.979B15.838B
cash and short term investments41.55B74.881B62.654B9.303B30.23B
net receivables86.366B79.629B76.13B63.107B75.261B
inventory42.853B37.944B36.356B33.60B31.811B
other current assets3.626B2.706B2.36B10.411B2.344B
total current assets174.395B195.16B177.50B116.421B139.646B
property plant equipment net172.376B119.832B109.98B98.23B90.961B
goodwill00004.464B
intangible assets109.379B055.501B59.64B55.942B
goodwill and intangible assets109.379B54.488B55.501B59.64B60.406B
long term investments2.70B2.047B1.659B1.651B1.663B
tax assets26.275B23.458B020.967B20.38B
other non current assets4.037B2.456B24.743B2.012B1.43B
total non current assets314.767B202.281B191.883B182.50B174.84B
other assets00000
total assets489.162B397.441B369.383B298.921B314.486B
account payables19.576B24.079B29.759B13.006B25.606B
short term debt22.413B5.52B5.452B10.164B6.478B
tax payables15.501B14.651B5.906B5.964B7.116B
deferred revenue0005.964B107.594B
other current liabilities178.627B164.108B146.792B136.472B29.977B
total current liabilities236.117B208.358B187.909B165.606B169.655B
long term debt96.31B51.452B51.608B16.764B20.528B
deferred revenue non current00007.391B
deferred tax liabilities non current8.705B8.655B09.664B10.162B
other non current liabilities9.49B8.454B17.344B17.64B189.00M
total non current liabilities114.505B68.561B68.952B34.404B38.27B
other liabilities00000
capital lease obligations00005.726B
total liabilities350.622B276.919B256.861B200.01B207.925B
preferred stock00000
common stock446.00M446.00M446.00M451.00M451.00M
retained earnings137.319B121.67B112.15B99.05B104.839B
accumulated other comprehensive income loss777.00M-1.593B-73.00M-585.00M1.276B
other total stockholders equity-2.00M-1.00M-1.00M-5.00M-5.00M
total stockholders equity138.54B120.522B112.522B98.911B106.561B
total equity138.54B120.522B112.522B98.911B106.561B
total liabilities and stockholders equity489.162B397.441B369.383B298.921B314.486B
minority interest00000
total investments5.312B19.91B11.492B4.63B17.501B
total debt118.723B56.972B57.06B26.928B27.006B
net debt79.785B-46.00M4.239B20.604B12.614B
Graph

Cash Flow

A cash flow statement is regarded as a valuable indicator of profitability and the long-term outlook for a company. It assists the company in evaluating whether it has sufficient funds to cover its expenses. Essentially, a cash flow statement represents an organization's financial health. The cash flow statement, which measures the business's ability to operate in the short as well as long term, is broken down into operating, investing, and financing activities.

DateJun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023
reported currencyDKKDKKDKKDKKDKK
calendar year20242024202320232023
periodQ2Q1Q4Q3Q2
deferred income tax5.282B6.511B5.657B5.585B4.826B
stock based compensation0023.579B-3.278B-4.544B
change in working capital9.101B-8.852B-9.683B11.669B-4.015B
accounts receivables00000
inventory00000
accounts payables00000
other working capital9.101B-8.852B000
other non cash items30.197B673.00M-34.957B1.987B10.705B
net cash provided by operating activities50.503B14.314B9.551B40.966B28.577B
investments in property plant and equipment-13.238B-9.009B-16.436B-10.624B-7.035B
acquisitions net-668.00M07.029B4.796B1.157B
purchases of investments-9.865B-1.16B-948.00M-4.831B-5.149B
sales maturities of investments3.04B14.125B2.667B2.212B2.899B
other investing activites-9.593B12.43B-7.029B-4.796B-1.157B
net cash used for investing activites-20.731B3.956B-14.717B-13.243B-9.285B
debt repayment-5.053B-317.00M-355.00M-261.00M-373.00M
common stock issued34.513B006.402B0
common stock repurchased-7.449B-2.836B-9.761B-6.141B-8.823B
dividends paid0-28.557B0-13.43B0
other financing activites-5.328B5.328B0-6.402B-3.393B
net cash used provided by financing activities16.683B-26.382B-10.116B-19.832B-12.589B
effect of forex changes on cash42.00M44.00M-209.00M418.00M-65.00M
net change in cash46.497B-8.068B-15.491B8.309B6.638B
cash at end of period52.821B6.324B14.392B29.883B21.574B
cash at beginning of period6.324B14.392B29.883B21.574B14.936B
operating cashflow50.503B14.314B9.551B40.966B28.577B
capital expenditure-13.238B-9.009B-16.436B-10.624B-7.035B
free cash flow37.265B5.305B-6.885B30.342B21.542B
Graph

Frequently Asked Questions

How did Novo Nordisk A/S do last quarter? What was its Total Revenue and Cost of Revenue?
A company's Total Revenue reveals how much money it generates before any expenses or deductions are made. As a result, this metric informs investors/stakeholders how much money the business makes. Tracking and understanding it is essential for evaluating a company's growth. As opposed to revenue, Cost of Revenue is any expenses a business incur to generate revenue. There can be high revenue in a business, but if the costs are high, it won't make a profit and will go out of business when money runs out. Therefore, NVO generated $78.09B in revenue last quarter, while its costs came in at $12.89B.
Last quarter, how much Gross Profit did Novo Nordisk A/S report?
A business's Gross Profit is a key indicator of its profitability and financial performance. In other words, it reflects how efficiently a business uses labor, raw materials, and other resources. Novo Nordisk A/S reported a $65.20B Gross Profit for the quarter ended Jun 30, 2024.
Have NVO's Total Operating Expenses and Operating Income been favorable recently?
Operational Expenses represent the costs a company must incur to generate revenue, which is the ultimate goal of a business, whereas Operating Income shows the revenue left after operational direct and indirect costs have been deducted. NVO incurred $26.41B worth of Operating Expenses, while it generated $38.79B worth of Operating Income.
How much Net Income has NVO posted recently?
The Net Income of a company is one of the factors investors consider when investing in the company. According to recent earnings report from Novo Nordisk A/S, the company generated $29.03B in Net Income. When a company has a history of consistent net income, investors are more likely to invest in it since they know they will get a return.
At the end of the last quarter, how much Cash and Equivalents did Novo Nordisk A/S have?
The amount of Cash and Cash Equivalents is an effective indicator of the financial strength and well-being of a company. An excess cash situation occurs when a company has more cash and cash equivalents than it needs for operating activities. The amount of Cash and Cash Equivalents available to Novo Nordisk A/S as of the end of the last quarter was $38.94B.
What are NVO's Total Net Receivables for the last quarter?
Total Net Receivables are a company's outstanding debts to its customers. Therefore, it refers to the amount that a company expects to collect from its customers. The higher a company's net receivables are, the more confident it is that it can collect money from its debtors. As of the end of the last quarter, NVO had Total Net Receivables of $86.37B.
In terms of Total Assets and Current Assets, where did Novo Nordisk A/S stand at?
An asset with an economic value within a year is considered a current asset. Total assets, however, also include long-term fixed assets, intangible assets, and other non-current assets. The current Assets of NVO were $174.40B, while the Total Assets stand at $489.16B.
As of the last quarter, how much Total Debt did Novo Nordisk A/S have?
The total debt of a business refers to how much it borrows. A company's current and long-term liabilities are added together to calculate its Total Debt. A debt ratio may be taken into account on a balance sheet by financial lenders, investors, and business leaders when making informed decisions about future loans or investments. The total amount of NVO's debt was $118.72B at the end of the last quarter.
What were NVO's Total Liabilities during the last reported quarter?
A company's total liabilities are the sum of all debts it is liable for, including any off-balance shee liabilities it may incur. This can be calculated by adding up all short-term and long-term liabilities. In its last quarter, NVO reported total liabilities of $350.62B.
How much did NVO's Working Capital change over the last quarter?
Working Capital Change for NVO was $9.10B over the last quarter. Working Capital Change refers to the difference between net working capital amounts at the end of one accounting period and the end of another. It tells investors/stakeholders how much the company's cash flow will differ from its Net Income (i.e., after-tax profits). More powerful companies often have positive Change in Working Capital numbers as they have increased control over collecting cash from customers and delaying payments to suppliers.
NVO generated how much cash from operating activities?
An operating cash flow statement usually contains cash from operating activities in the first section. An organization's cash from operating activities refers to the money it takes in and takes out as a result of its regular business operations. NVO generated $50.50B of Cash from Operating Activities during its recently reported quarter.
What was NVO's latest reported Net Change in Cash?
An increase or decrease in cash and cash equivalent balances within a specified period is considered the net change in cash in a cash flow statement. Furthermore, it takes into account cash changes as a result of investments, financing, and operating activities. NVO reported a $46.50B Net Change in Cash in the most recent quarter.
logo

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep

stockstelegraph

Don't have an account?

stockstelegraph

Don't have an account?

stockstelegraph

Already have an account?

stockstelegraph
Smart Screening Tools for Exceptional Returns
stockstelegraph

For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market. Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.

Ready to Win Big?

Try Now for Just $1!
stockstelegraph